StockMap tracks 834 large-cap U.S. stocks in the Health Care sector. Their combined market capitalisation is $9.86T. On the most recent trading day the sector was down 1.57% on average. Its largest constituents by market capitalisation are LLY, JNJ, ABBV, MRK, UNH. 428 of its stocks are leaning below IVW and 46 above. Every stock in this sector carries a conviction signal and a two-week outlook, and calls that lean one way are graded in public once their window closes. Over the 30 days to Oct 19, 14,633 calls were graded. Against each stock's sector median, 59.3% were right, where the base rate is 50.0%. Against IVW, 67.7% were right, where the base rate is 54.2%.
| Symbol | Name | Cap |
|---|---|---|
| LLY | Eli Lilly and Company | $1.33T |
| JNJ | Johnson & Johnson | $657.68B |
| ABBV | AbbVie | $521.11B |
| MRK | Merck & Company Inc. Common Stock (new) | $368.89B |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | $365.29B |
| NVS | Novartis | $303.67B |
| AZN | AstraZeneca | $289.50B |
| TMO | Thermo Fisher Scientific | $257.71B |
| AMGN | Amgen | $251.94B |
| GILD | Gilead Sciences | $211.64B |
| ABT | Abbott Laboratories | $183.77B |
| PFE | Pfizer | $173.95B |
| DHR | Danaher | $163.38B |
| ISRG | Intuitive Surgical | $149.75B |
| VRTX | Vertex Pharmaceuticals Incorporated | $141.65B |
| NVO | Novo Nordisk A/S | $134.03B |
| BMY | Bristol-Myers Squibb Company | $127.71B |
| MDT | Medtronic plc | $123.49B |
| MCK | McKesson | $115.96B |
| CVS | CVS Health | $115.43B |
| SYK | Stryker | $111.95B |
| SNY | Sanofi ADS | $106.24B |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | $100.14B |
| HCA | HCA Healthcare | $98.85B |
| REGN | Regeneron Pharmaceuticals | $95.53B |
| ELV | Elevance Health | $90.76B |
| MRNA | Moderna | $88.52B |
| CI | The Cigna Group | $78.80B |
| TAK | Takeda Pharmaceutical Company | $66.81B |
| COR | Cencora | $63.13B |
| BSX | Boston Scientific | $60.84B |
| NTRA | Natera | $59.72B |
| CAH | Cardinal Health | $58.00B |
| ARGX | argenx | $55.84B |
| BDX | Becton Dickinson and Company | $53.90B |
| EW | Edwards Lifesciences | $53.03B |
| VEEV | Veeva Systems | $50.67B |
| HUM | Humana | $49.77B |
| A | Agilent Technologies | $49.30B |
| TEVA | Teva Pharmaceutical Industries | $49.05B |
| WAT | Waters | $45.46B |
| IQV | IQVIA Holdings | $44.06B |
| IDXX | IDEXX Laboratories | $43.42B |
| MDLN | Medline | $42.23B |
| RVMD | Revolution Medicines | $41.00B |
| ONC | BeOne Medicines | $40.66B |
| RPRX | Royalty Pharma | $38.63B |
| HLN | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | $38.09B |
| BIIB | Biogen | $37.49B |
| ILMN | Illumina | $35.63B |
| GMAB | Genmab A/S ADS | $35.06B |
| ALC | Alcon | $34.82B |
| GEHC | GE HealthCare Technologies | $34.62B |
| CNC | Centene | $33.89B |
| MTD | Mettler-Toledo International | $33.56B |
| ZTS | Zoetis | $32.94B |
| RMD | ResMed | $32.34B |
| DXCM | DexCom | $30.69B |
| LH | Labcorp Holdings | $29.34B |
| WST | West Pharmaceutical Services | $28.74B |
| DGX | Quest Diagnostics Incorporated | $27.70B |
| ROIV | Roivant Sciences Ltd. Common Shares | $26.66B |
| PHG | Koninklijke Philips N.V. NY Registry Shares | $26.31B |
| UTHR | United Therapeutics | $25.68B |
| INSM | Insmed Incorporated | $24.70B |
| INCY | Incyte | $24.54B |
| GH | Guardant Health | $23.99B |
| BNTX | BioNTech SE American Depositary Share | $22.15B |
| STE | STERIS plc (Ireland) | $22.14B |
| ALNY | Alnylam Pharmaceuticals | $22.10B |
| VTRS | Viatris | $21.86B |
| THC | Tenet Healthcare | $21.75B |
| MEDP | Medpace Holdings | $18.24B |
| ZBH | Zimmer Biomet Holdings | $18.03B |
| RVTY | Revvity | $17.52B |
| CRL | Charles River Laboratories International | $17.16B |
| EXEL | Exelixis | $16.93B |
| ASND | Ascendis Pharma A/S Ordinary Share | $16.68B |
| ICLR | ICON | $15.83B |
| HALO | Halozyme Therapeutics | $14.86B |
| NBIX | Neurocrine Biosciences | $14.85B |
| BBIO | BridgeBio Pharma | $14.60B |
| GKOS | Glaukos | $14.07B |
| JAZZ | Jazz Pharmaceuticals plc Common Stock (Ireland) | $14.02B |
| SOLV | Solventum | $13.84B |
| EHC | Encompass Health | $13.41B |
| TEM | Tempus AI | $13.16B |
| SMMT | Summit Therapeutics | $12.82B |
| PEN | Penumbra | $12.57B |
| SNN | Smith & Nephew SNATS | $12.44B |
| FMS | Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) | $11.96B |
| BAX | Baxter International | $11.90B |
| RDY | Dr. Reddy's Laboratories | $11.80B |
| DVA | DaVita | $11.79B |
| ELAN | Elanco Animal Health Incorporated | $11.52B |
| TECH | Bio-Techne | $11.41B |
| BMRN | BioMarin Pharmaceutical | $11.33B |
| COO | The Cooper Companies | $11.32B |
| RGEN | Repligen | $11.23B |
| AVTR | Avantor | $10.88B |
| KYMR | Kymera Therapeutics | $10.81B |
| MOH | Molina Healthcare | $10.69B |
| ALGN | Align Technology | $10.65B |
| ENSG | The Ensign Group | $10.59B |
| GMED | Globus Medical | $10.48B |
| PODD | Insulet | $10.38B |
| UHS | Universal Health Services | $10.38B |
| QGEN | Qiagen N.V. Common Shares | $10.37B |
| TWST | Twist Bioscience | $10.12B |
| MDGL | Madrigal Pharmaceuticals | $9.94B |
| KRYS | Krystal Biotech | $9.84B |
| CAI | Caris Life Sciences | $9.70B |
| HSIC | Henry Schein | $9.46B |
| PCVX | Vaxcyte | $9.44B |
| PTGX | Protagonist Therapeutics | $9.37B |
| TGTX | TG Therapeutics | $9.36B |
| HNGE | Hinge Health | $9.22B |
| TXG | 10x Genomics | $9.13B |
| SYRE | Spyre Therapeutics | $8.90B |
| CORT | Corcept Therapeutics Incorporated | $8.77B |
| CYTK | Cytokinetics Incorporated | $8.76B |
| BRKR | Bruker | $8.70B |
| HQY | HealthEquity | $8.48B |
| ARWR | Arrowhead Pharmaceuticals | $8.46B |
| BIO | Bio-Rad Laboratories | $8.07B |
| PRAX | Praxis Precision Medicines | $7.98B |
| ALKS | Alkermes | $7.61B |
| PACS | PACS Group | $7.57B |
| AXSM | Axsome Therapeutics | $7.57B |
| AMRX | Amneal Pharmaceuticals | $7.49B |
| KNSA | Kiniksa Pharmaceuticals International | $7.25B |
| IONS | Ionis Pharmaceuticals | $7.23B |
| BLCO | Bausch + Lomb Corporation Common Shares | $7.15B |
| CHE | Chemed | $6.96B |
| ABVX | Abivax SA | $6.91B |
| LNTH | Lantheus Holdings | $6.56B |
| HIMS | Hims & Hers Health | $6.46B |
| LGND | Ligand Pharmaceuticals Incorporated | $6.43B |
| ORKA | Oruka Therapeutics | $6.41B |
| GRAL | GRAIL | $6.41B |
| RYTM | Rhythm Pharmaceuticals | $6.37B |
| KOD | Kodiak Sciences | $6.23B |
| BLTE | Belite Bio | $6.23B |
| IMVT | Immunovant | $6.03B |
| TFX | Teleflex Incorporated | $5.92B |
| DOCS | Doximity | $5.84B |
| MANE | Veradermics Incorporated | $5.84B |
| RDNT | RadNet | $5.78B |
| CGON | CG Oncology Inc. Common stock | $5.73B |
| MIRM | Mirum Pharmaceuticals | $5.52B |
| HAE | Haemonetics | $5.44B |
| COGT | Cogent Biosciences | $5.38B |
| WAY | Waystar Holding | $5.37B |
| BLLN | BillionToOne | $5.35B |
| SRRK | Scholar Rock Holding | $5.35B |
| STVN | Stevanato Group S.p.A | $5.29B |
| SHC | Sotera Health Company | $5.18B |
| MMSI | Merit Medical Systems | $5.17B |
| MMED | MiniMed Group | $5.14B |
| HTFL | Heartflow | $5.13B |
| LFST | LifeStance Health Group | $5.12B |
| CON | Concentra Group Holdings Parent | $5.11B |
| ERAS | Erasca | $5.02B |
| PTCT | PTC Therapeutics | $5.01B |
| CRSP | CRISPR Therapeutics AG Common Shares | $4.97B |
| DFTX | Definium Therapeutics Inc. Common Shares | $4.88B |
| OPCH | Option Care Health | $4.77B |
| TVTX | Travere Therapeutics | $4.75B |
| DNTH | Dianthus Therapeutics | $4.61B |
| CDNA | CareDx | $4.59B |
| LIVN | LivaNova | $4.35B |
| ITGR | Integer Holdings | $4.30B |
| ADPT | Adaptive Biotechnologies | $4.25B |
| EWTX | Edgewise Therapeutics | $4.22B |
| LEGN | Legend Biotech | $4.21B |
| INDV | Indivior Pharmaceuticals | $4.17B |
| CRVL | CorVel | $4.15B |
| ICUI | ICU Medical | $4.10B |
| IRTC | iRhythm Holdings | $4.07B |
| LQDA | Liquidia | $4.03B |
| ARQT | Arcutis Biotherapeutics | $4.03B |
| RLAY | Relay Therapeutics | $4.02B |
| VCYT | Veracyte | $4.02B |
| ABCL | AbCellera Biologics Inc. Common Shares | $3.97B |
| IOVA | Iovance Biotherapeutics | $3.84B |
| TNGX | Tango Therapeutics | $3.83B |
| NVST | Envista Holdings | $3.78B |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | $3.73B |
| TARS | Tarsus Pharmaceuticals | $3.66B |
| OGN | Organon & Co | $3.63B |
| XENE | Xenon Pharmaceuticals Inc. Common Shares | $3.62B |
| AMLX | Amylyx Pharmaceuticals | $3.62B |
| IRON | Disc Medicine | $3.58B |
| ACAD | ACADIA Pharmaceuticals | $3.55B |
| VKTX | Viking Therapeutics | $3.48B |
| PBLS | Parabilis Medicines | $3.45B |
| CELC | Celcuity | $3.38B |
| RGC | Regencell Bioscience Holdings | $3.33B |
| ELVN | Enliven Therapeutics | $3.24B |
| NHC | National HealthCare | $3.23B |
| DYN | Dyne Therapeutics | $3.12B |
| ATRC | AtriCure | $3.12B |
| TLX | Telix Pharmaceuticals | $3.10B |
| IDYA | IDEAYA Biosciences | $3.08B |
| BHC | Bausch Health Companies | $3.07B |
| DNLI | Denali Therapeutics | $3.03B |
| SGRY | Surgery Partners | $2.99B |
| AXGN | Axogen | $2.95B |
| NRIX | Nurix Therapeutics Inc. Common stock | $2.93B |
| AVAH | Aveanna Healthcare Holdings | $2.87B |
| ASST | Strive | $2.83B |
| BEAM | Beam Therapeutics | $2.81B |
| VRDN | Viridian Therapeutics | $2.79B |
| ACHC | Acadia Healthcare Company | $2.79B |
| ZLAB | Zai Lab | $2.76B |
| PRVA | Privia Health Group | $2.74B |
| MBX | MBX Biosciences | $2.69B |
| RCUS | Arcus Biosciences | $2.61B |
| NEOG | Neogen | $2.58B |
| GRDN | Guardian Pharmacy Services | $2.58B |
| ADMA | ADMA Biologics | $2.56B |
| PGEN | Precigen | $2.48B |
| BKD | Brookdale Senior Living | $2.48B |
| SUPN | Supernus Pharmaceuticals | $2.44B |
| NAMS | NewAmsterdam Pharma Company | $2.40B |
| RXRX | Recursion Pharmaceuticals | $2.40B |
| CLOV | Clover Health Investments | $2.37B |
| CLDX | Celldex Therapeutics | $2.36B |
| PHVS | Pharvaris | $2.35B |
| ADUS | Addus HomeCare | $2.34B |
| MD | Pediatrix Medical Group | $2.33B |
| BHVN | Biohaven Ltd. Common Shares | $2.33B |
| PBH | Prestige Consumer Healthcare | $2.32B |
| HCM | HUTCHMED (China) | $2.29B |
| TMDX | TransMedics Group | $2.29B |
| HRMY | Harmony Biosciences Holdings | $2.26B |
| NEO | NeoGenomics | $2.25B |
| PGNY | Progyny | $2.24B |
| VERA | Vera Therapeutics | $2.23B |
| XNCR | Xencor | $2.22B |
| AUPH | Aurinia Pharmaceuticals | $2.22B |
| UFPT | UFP Technologies | $2.20B |
| PRGO | Perrigo Company | $2.19B |
| BCRX | BioCryst Pharmaceuticals | $2.16B |
| IMNM | Immunome | $2.15B |
| LKFT | Lakefront Biotherapeutics | $2.12B |
| PVLA | Palvella Therapeutics | $2.11B |
| GRFS | Grifols | $2.09B |
| VCEL | Vericel | $2.06B |
| WGS | GeneDx Holdings | $2.06B |
| FTRE | Fortrea Holdings | $2.05B |
| SEPN | Septerna | $2.05B |
| SDGR | Schrodinger | $2.03B |
| MRVI | Maravai LifeSciences Holdings | $2.03B |
| ZYME | Zymeworks | $2.02B |
| TRLV | Trulieve Cannabis Corp. Subordinate Voting Shares | $1.98B |
| MESO | Mesoblast | $1.97B |
| INSP | Inspire Medical Systems | $1.97B |
| SRPT | Sarepta Therapeutics Inc. Common Stock (DE) | $1.97B |
| SLS | SELLAS Life Sciences Group | $1.95B |
| XERS | Xeris Biopharma Holdings | $1.95B |
| COAG | Hemab Therapeutics Holdings | $1.94B |
| TRVI | Trevi Therapeutics | $1.93B |
| BIO_B | Bio-Rad Laboratories | $1.92B |
| VIR | Vir Biotechnology | $1.91B |
| ABSI | Absci | $1.91B |
| XRAY | DENTSPLY SIRONA | $1.90B |
| TRAX | First Tracks Biotherapeutics | $1.89B |
| ESTA | Establishment Labs Holdings Inc. Common Shares | $1.86B |
| GENB | Generate Biomedicines | $1.86B |
| LMAT | LeMaitre Vascular | $1.85B |
| ZBIO | Zenas BioPharma | $1.85B |
| AMN | AMN Healthcare Services | $1.82B |
| AGIO | Agios Pharmaceuticals | $1.82B |
| ASTH | Astrana Health | $1.81B |
| KMTS | Kestra Medical Technologies | $1.77B |
| NTLA | Intellia Therapeutics | $1.75B |
| QURE | uniQure | $1.72B |
| PSNL | Personalis | $1.71B |
| AZTA | Azenta | $1.71B |
| BFLY | Butterfly Network | $1.71B |
| STOK | Stoke Therapeutics | $1.70B |
| MAZE | Maze Therapeutics | $1.70B |
| ARDT | Ardent Health | $1.70B |
| CERT | Certara | $1.68B |
| OMCL | Omnicell Inc. Common Stock ($0.001 par value) | $1.67B |
| NUVB | Nuvation Bio | $1.67B |
| REPL | Replimune Group | $1.67B |
| KLRA | Kailera Therapeutics | $1.67B |
| NVAX | Novavax | $1.66B |
| ALVO | Alvotech | $1.66B |
| ANIP | ANI Pharmaceuticals | $1.65B |
| SNDA | Sonida Senior Living | $1.65B |
| MLYS | Mineralys Therapeutics | $1.61B |
| CMPS | COMPASS Pathways Plc American Depository Shares | $1.60B |
| URGN | UroGen Pharma | $1.60B |
| IMCR | Immunocore Holdings | $1.59B |
| RARE | Ultragenyx Pharmaceutical | $1.59B |
| PAHC | Phibro Animal Health | $1.58B |
| TDOC | Teladoc Health | $1.55B |
| NVCR | NovoCure | $1.54B |
| INVA | Innoviva | $1.53B |
| OCUL | Ocular Therapeutix | $1.53B |
| ALHC | Alignment Healthcare | $1.52B |
| NBTX | Nanobiotix | $1.52B |
| ETON | Eton Pharmaceuticals | $1.49B |
| PNTG | The Pennant Group | $1.46B |
| PCRX | Pacira BioSciences | $1.45B |
| TYRA | Tyra Biosciences | $1.45B |
| RAPP | Rapport Therapeutics | $1.45B |
| ANAB | AnaptysBio | $1.44B |
| GHRS | GH Research | $1.43B |
| AGL | agilon health inc | $1.43B |
| NUTX | Nutex Health | $1.37B |
| AAPG | Ascentage Pharma Group International American Depository Shares | $1.36B |
| TSHA | Taysha Gene Therapies | $1.35B |
| OMER | Omeros | $1.33B |
| TNDM | Tandem Diabetes Care | $1.33B |
| NKTR | Nektar Therapeutics | $1.33B |
| DMRA | Damora Therapeutics | $1.33B |
| KARD | Kardigan | $1.32B |
| CNMD | CONMED | $1.32B |
| USPH | U.S. Physical Therapy | $1.28B |
| LBRX | LB Pharmaceuticals | $1.28B |
| INNV | InnovAge Holding | $1.25B |
| OPK | OPKO Health | $1.24B |
| STAA | STAAR Surgical Company | $1.23B |
| SLN | Silence Therapeutics Plc American Depository Share | $1.23B |
| SNDX | Syndax Pharmaceuticals | $1.22B |
| CRON | Cronos Group Inc. Common Share | $1.22B |
| VOR | Vor Biopharma | $1.21B |
| DRTS | Alpha Tau Medical | $1.21B |
| GDRX | GoodRx Holdings | $1.19B |
| VSTM | Verastem | $1.18B |
| AMPH | Amphastar Pharmaceuticals | $1.18B |
| ENOV | Enovis | $1.15B |
| OMDA | Omada Health | $1.15B |
| AVLN | Avalyn Pharma | $1.14B |
| CSTL | Castle Biosciences | $1.14B |
| MNKD | MannKind | $1.13B |
| BVS | Bioventus | $1.12B |
| AORT | Artivion | $1.10B |
| PRCT | PROCEPT BioRobotics | $1.10B |
| LMRI | Lumexa Imaging Holdings | $1.10B |
| IMTX | Immatics | $1.10B |
| ATEC | Alphatec Holdings | $1.09B |
| SGP | SpyGlass Pharma | $1.08B |
| JANX | Janux Therapeutics | $1.07B |
| HROW | Harrow | $1.06B |
| INBX | Inhibrx Biosciences | $1.06B |
| SPTX | Seaport Therapeutics | $1.05B |
| CBLL | CeriBell | $1.02B |
| MLTX | MoonLake Immunotherapeutics | $1.00B |
| IART | Integra LifeSciences Holdings | $991.96M |
| SVRA | Savara | $990.32M |
| HSTM | HealthStream | $985.39M |
| IRMD | iRadimed | $980.51M |
| CGEM | Cullinan Therapeutics | $967.26M |
| RIGL | Rigel Pharmaceuticals | $958.47M |
| ORIC | Oric Pharmaceuticals | $957.75M |
| SIBN | SI-BONE | $951.51M |
| ODTX | Odyssey Therapeutics | $939.07M |
| GLUE | Monte Rosa Therapeutics | $917.97M |
| KURA | Kura Oncology | $912.74M |
| MGTX | MeiraGTx Holdings | $911.45M |
| BBNX | Beta Bionics | $910.65M |
| QDEL | QuidelOrtho | $908.62M |
| JBIO | Jade Biosciences | $894.17M |
| ANRO | Alto Neuroscience | $886.87M |
| CYRX | CryoPort | $875.72M |
| ALMS | Alumis | $871.10M |
| PHAR | Pharming Group N.V. ADS each representing 10 ordinary shares | $866.25M |
| IVA | Inventiva S.A. American Depository Shares | $862.42M |
| AKTS | Aktis Oncology Inc. Common stock | $856.19M |
| PRME | Prime Medicine | $856.10M |
| CRVS | Corvus Pharmaceuticals | $843.73M |
| HELP | Helus Pharma | $843.28M |
| ABUS | Arbutus Biopharma | $834.03M |
| PACB | Pacific Biosciences of California | $809.71M |
| KIDS | OrthoPediatrics | $806.02M |
| CTKB | Cytek Biosciences | $796.80M |
| AHCO | AdaptHealth | $792.16M |
| VREX | Varex Imaging | $782.59M |
| COLL | Collegium Pharmaceutical | $774.83M |
| PHR | Phreesia | $772.16M |
| SANA | Sana Biotechnology | $769.36M |
| ANNX | Annexon | $767.79M |
| INMD | InMode | $760.73M |
| ARDX | Ardelyx | $755.04M |
| AVBP | ArriVent BioPharma | $733.21M |
| DNA | Ginkgo Bioworks Holdings | $721.25M |
| MLAB | Mesa Laboratories | $715.22M |
| WVE | Wave Life Sciences | $708.05M |
| ACHV | Achieve Life Sciences Inc. Common Shares | $702.82M |
| SGMT | Sagimet Biosciences Inc. Series A | $699.69M |
| ANL | Adlai Nortye Group | $669.08M |
| DSGN | Design Therapeutics | $668.38M |
| STLN | Starling Oncology | $665.51M |
| SLDB | Solid Biosciences | $664.79M |
| FDMT | 4D Molecular Therapeutics | $657.40M |
| SOPH | SOPHiA GENETICS SA | $649.53M |
| CADL | Candel Therapeutics | $637.40M |
| AURA | Aura Biosciences | $636.75M |
| IMMX | Immix Biopharma | $636.66M |
| LXRX | Lexicon Pharmaceuticals | $631.84M |
| OLMA | Olema Pharmaceuticals | $612.49M |
| ZVRA | Zevra Therapeutics | $610.47M |
| MYGN | Myriad Genetics | $607.38M |
| GMRS | GMR Solutions | $604.51M |
| BCAX | Bicara Therapeutics | $604.16M |
| NVCT | Nuvectis Pharma | $602.12M |
| DBVT | DBV Technologies | $596.40M |
| CLYM | Climb Bio | $588.72M |
| ACRS | Aclaris Therapeutics | $586.01M |
| IRWD | Ironwood Pharmaceuticals | $578.34M |
| GERN | Geron | $574.63M |
| FLGT | Fulgent Genetics | $567.36M |
| MDXG | MiMedx Group | $566.19M |
| STTK | Shattuck Labs | $558.02M |
| ENTX | Entera Bio | $556.55M |
| NGNE | Neurogene | $551.30M |
| SBC | SBC Medical Group Holdings Incorporated | $542.52M |
| PBYI | Puma Biotechnology | $538.91M |
| TCMD | Tactile Systems Technology | $521.90M |
| SRZN | Surrozen | $516.91M |
| VALN | Valneva | $516.79M |
| ARVN | Arvinas | $513.93M |
| SGHT | Sight Sciences | $513.42M |
| OCS | Oculis Holding AG Ordinary shares | $509.91M |
| CTMX | CytomX Therapeutics | $509.88M |
| NRC | NRC Health | $505.72M |
| ANGO | AngioDynamics | $504.23M |
| SENS | Senseonics Holdings | $502.83M |
| CBIO | Crescent Biopharma | $500.70M |
| DMAC | DiaMedica Therapeutics | $498.82M |
| OVID | Ovid Therapeutics | $496.06M |
| AQST | Aquestive Therapeutics | $488.24M |
| DCTH | Delcath Systems | $487.17M |
| EVH | Evolent Health | $486.15M |
| EOLS | Evolus | $485.47M |
| RCEL | Avita Medical | $484.01M |
| GYRE | Gyre Therapeutics | $482.98M |
| FTH | Faeth Therapeutics | $482.95M |
| RGNX | REGENXBIO | $475.29M |
| MNPR | Monopar Therapeutics | $471.99M |
| SSII | SS Innovations International | $471.15M |
| PHAT | Phathom Pharmaceuticals | $466.62M |
| CERS | Cerus | $459.48M |
| BWAY | BrainsWay | $457.27M |
| TKNO | Alpha Teknova | $454.13M |
| KMDA | Kamada | $444.14M |
| EPRX | Eupraxia Pharmaceuticals | $444.08M |
| CRMD | CorMedix | $443.89M |
| PRTA | Prothena | $434.82M |
| NPCE | Neuropace | $422.19M |
| MPLT | MapLight Therapeutics | $421.27M |
| YDES | YD Bio | $420.81M |
| CCCC | C4 Therapeutics | $414.59M |
| EDIT | Editas Medicine | $410.06M |
| ASMB | Assembly Biosciences | $409.87M |
| CARL | Carlsmed | $408.18M |
| ALLO | Allogene Therapeutics | $407.68M |
| CTEV | Claritev | $406.73M |
| AUTL | Autolus Therapeutics plc American Depositary Share | $404.57M |
| SI | Shoulder Innovations | $398.27M |
| ALT | Altimmune | $396.82M |
| SRTA | Strata Critical Medical | $392.79M |
| ZURA | Zura Bio | $389.15M |
| TECX | Tectonic Therapeutic | $386.68M |
| AVTX | Avalo Therapeutics | $384.53M |
| RZLT | Rezolute Inc. Common Stock (NV) | $382.08M |
| RLMD | Relmada Therapeutics | $381.88M |
| TLRY | Tilray Brands | $373.90M |
| CAPR | Capricor Therapeutics | $370.93M |
| OFIX | Orthofix Medical Inc. Common Stock (DE) | $369.45M |
| AGMB | AgomAb Therapeutics NV | $368.87M |
| VMD | Viemed Healthcare Inc. Common Shares | $368.31M |
| CV | CapsoVision | $363.33M |
| FENC | Fennec Pharmaceuticals | $358.99M |
| OBIO | Orchestra BioMed Holdings | $355.22M |
| EMBC | Embecta | $354.12M |
| CTNM | Contineum Therapeutics | $353.26M |
| MOBI | Mobia Medical | $352.22M |
| KYTX | Kyverna Therapeutics | $350.65M |
| EBS | Emergent BioSolutions | $349.17M |
| CLPT | ClearPoint Neuro | $342.02M |
| CYH | Community Health Systems | $338.46M |
| SPRY | ARS Pharmaceuticals | $336.13M |
| GALT | Galectin Therapeutics | $334.82M |
| AUNA | Auna SA | $333.80M |
| XFOR | X4 Pharmaceuticals | $332.14M |
| AVIR | Atea Pharmaceuticals | $329.64M |
| ALEC | Alector | $327.65M |
| TTRX | Turn Therapeutics | $318.46M |
| ARCT | Arcturus Therapeutics Holdings | $313.51M |
| ENTA | Enanta Pharmaceuticals | $311.93M |
| PRLD | Prelude Therapeutics Incorporated | $309.64M |
| AGEN | Agenus | $307.94M |
| VFF | Village Farms International Inc. Common Shares | $305.71M |
| IRD | Opus Genetics | $305.33M |
| BNTC | Benitec Biopharma | $304.93M |
| SABS | SAB Biotherapeutics | $304.80M |
| PRE | Prenetics Global Limited Class A Ordinary Share | $304.46M |
| SNDL | SNDL Inc. Common Shares | $301.69M |
| SMTI | Sanara MedTech | $301.64M |
| TMCI | Treace Medical Concepts | $288.11M |
| EIKN | Eikon Therapeutics | $287.62M |
| FULC | Fulcrum Therapeutics | $283.06M |
| ANIK | Anika Therapeutics | $280.37M |
| INFU | InfuSystems Holdings | $280.23M |
| CGC | Canopy Growth Corporation Common Shares | $276.24M |
| OSUR | OraSure Technologies | $271.74M |
| LYEL | Lyell Immunopharma | $270.54M |
| BIOA | BioAge Labs | $269.42M |
| RCKT | Rocket Pharmaceuticals | $267.85M |
| QTTB | Q32 Bio | $265.24M |
| ACB | Aurora Cannabis Inc. Common Shares | $263.26M |
| ACU | Acme United Corporation | $257.87M |
| LXEO | Lexeo Therapeutics | $257.77M |
| LRMR | Larimar Therapeutics | $256.59M |
| BCYC | Bicycle Therapeutics | $256.54M |
| CABA | Cabaletta Bio | $256.01M |
| CUVL | Clinuvel Pharmaceuticals | $255.97M |
| AMRN | Amarin | $255.80M |
| GLSI | Greenwich LifeSciences | $255.54M |
| FATE | Fate Therapeutics | $249.23M |
| ABEO | Abeona Therapeutics | $248.75M |
| CAMP | CAMP4 Therapeutics | $248.50M |
| BDSX | Biodesix | $245.36M |
| IFRX | InflaRx | $244.63M |
| EVMN | Evommune | $244.25M |
| IMRX | Immuneering | $242.54M |
| PROF | Profound Medical | $240.21M |
| OCGN | Ocugen | $238.29M |
| VNDA | Vanda Pharmaceuticals | $229.18M |
| TLSI | TriSalus Life Sciences | $227.83M |
| ACIU | AC Immune SA | $225.94M |
| ELDN | Eledon Pharmaceuticals | $225.09M |
| ELMD | Electromed | $224.08M |
| SLGL | Sol-Gel Technologies | $223.78M |
| KROS | Keros Therapeutics | $218.89M |
| SIGA | SIGA Technologies | $218.42M |
| AMWL | American Well | $216.52M |
| IKT | Inhibikase Therapeutics | $216.28M |
| UTMD | Utah Medical Products | $216.14M |
| KRRO | Korro Bio | $210.80M |
| BBOT | BridgeBio Oncology Therapeutics | $210.06M |
| XGN | Exagen | $208.09M |
| ARTV | Artiva Biotherapeutics | $204.85M |
| RXST | RxSight | $202.56M |
| FOCL | EDAP TMS | $197.17M |
| RNAC | Cartesian Therapeutics | $196.35M |
| PRQR | ProQR Therapeutics | $196.16M |
| ADCT | ADC Therapeutics SA Common Shares | $195.33M |
| DTIL | Precision BioSciences | $194.87M |
| ACOG | Alpha Cognition | $190.34M |
| UPB | Upstream Bio | $186.77M |
| PDEX | Pro-Dex | $186.11M |
| ZNTL | Zentalis Pharmaceuticals | $185.55M |
| WHWK | Whitehawk Therapeutics | $184.71M |
| RNA | Atrium Therapeutics | $184.22M |
| INGN | Inogen | $182.05M |
| TRDA | Entrada Therapeutics | $176.58M |
| OPRX | OptimizeRx | $175.55M |
| SION | Sionna Therapeutics | $174.97M |
| MDWD | MediWound | $171.70M |
| STIM | Neuronetics | $171.44M |
| ORMP | Oramed Pharmaceuticals | $170.96M |
| ANTX | AN2 Therapeutics | $170.94M |
| ADAG | Adagene | $168.53M |
| IPHA | Innate Pharma S.A. ADS | $163.08M |
| CNTN | Canton Strategic Holdings | $155.38M |
| MGNX | MacroGenics | $152.88M |
| ALXO | ALX Oncology Holdings | $152.41M |
| CUE | Cue Biopharma | $151.60M |
| STRO | Sutro Biopharma | $150.89M |
| NNNN | Anbio Biotechnology | $147.47M |
| NGEN | NervGen Pharma Corp. Common stock | $147.43M |
| TARA | Protara Therapeutics | $146.56M |
| MSLE | Satellos Bioscience | $142.15M |
| CMPX | Compass Therapeutics | $141.64M |
| NBP | NovaBridge Biosciences | $140.67M |
| KRMD | KORU Medical Systems Inc. Common Stock (DE) | $138.05M |
| QTRX | Quanterix | $137.39M |
| MOLN | Molecular Partners | $137.13M |
| HSDT | Solana Company Class A Common Stock (DE) | $136.07M |
| SPRB | Spruce Biosciences | $133.32M |
| OGI | Organigram Global Inc. Common Shares | $131.57M |
| CATX | Perspective Therapeutics | $131.27M |
| CDXS | Codexis | $130.31M |
| KZIA | Kazia Therapeutics | $129.59M |
| LUNG | Pulmonx | $129.06M |
| CHRS | Coherus Oncology | $128.25M |
| HCAT | Health Catalyst | $127.18M |
| AIRS | AirSculpt Technologies | $124.72M |
| FHTX | Foghorn Therapeutics | $123.52M |
| ARMP | Armata Pharmaceuticals | $121.96M |
| OWLT | Owlet | $118.35M |
| DERM | Journey Medical | $114.90M |
| BNR | Burning Rock Biotech | $114.65M |
| OTLK | Outlook Therapeutics | $113.96M |
| NKTX | Nkarta | $111.73M |
| NERV | Minerva Neurosciences | $110.78M |
| LFMD | LifeMD | $110.38M |
| AVXL | Anavex Life Sciences | $110.31M |
| APYX | Apyx Medical | $109.52M |
| PYPD | PolyPid | $109.48M |
| ANIX | Anixa Biosciences | $108.46M |
| NAKA | Nakamoto | $107.51M |
| VYGR | Voyager Therapeutics | $105.98M |
| PDSB | PDS Biotechnology | $104.36M |
| UNCY | Unicycive Therapeutics | $104.18M |
| ENGN | enGene Therapeutics | $102.53M |
| IMUX | Immunic | $102.47M |
| BDTX | Black Diamond Therapeutics | $102.27M |
| PARK | Park Dental Partners | $100.28M |
| VTVT | vTv Therapeutics | $99.52M |
| JYNT | The Joint | $99.43M |
| PMVP | PMV Pharmaceuticals | $98.92M |
| ORGO | Organogenesis Holdings | $98.84M |
| NRXP | NRX Pharmaceuticals | $98.28M |
| IMDX | Insight Molecular Diagnostics | $96.86M |
| KEQU | Kewaunee Scientific | $96.81M |
| LENZ | LENZ Therapeutics | $95.83M |
| NTHI | NeOnc Technologies Holdings | $93.90M |
| ICCC | ImmuCell | $93.18M |
| SEER | Seer | $93.02M |
| MIST | Milestone Pharmaceuticals Inc. Common Shares | $90.88M |
| NRXS | Neuraxis | $89.54M |
| NYXH | Nyxoah SA | $88.75M |
| TNXP | Tonix Pharmaceuticals Holding | $87.47M |
| PLYX | Polaryx Therapeutics | $87.23M |
| EQ | Equillium | $86.87M |
| STXS | Stereotaxis | $86.43M |
| COYA | Coya Therapeutics | $84.68M |
| RLYB | Rallybio | $83.67M |
| CRBP | Corbus Pharmaceuticals Holdings | $81.62M |
| ATRA | Atara Biotherapeutics | $80.40M |
| CLLS | Cellectis | $78.51M |
| NTRB | Nutriband | $76.58M |
| OM | Outset Medical | $75.75M |
| CCLD | CareCloud | $74.79M |
| MBOT | Microbot Medical | $73.21M |
| CING | Cingulate | $72.42M |
| LNSR | LENSAR | $71.75M |
| CPIX | Cumberland Pharmaceuticals | $70.27M |
| CRDF | Cardiff Oncology | $69.21M |
| BMGL | Basel Medical Group | $68.45M |
| ECOR | electroCore | $67.80M |
| TENX | Tenax Therapeutics | $66.99M |
| CSBR | Champions Oncology | $66.95M |
| FBIO | Fortress Biotech | $64.03M |
| GOSS | Gossamer Bio | $63.48M |
| SPRO | Spero Therapeutics | $61.73M |
| APLM | Apollomics | $60.31M |
| VRCA | Verrica Pharmaceuticals | $57.55M |
| NMAD | Nomad Power Solutions | $57.32M |
| XBIT | XBiotech | $57.32M |
| RFL | Rafael Holdings | $56.36M |
| CLNN | Clene | $54.44M |
| ELOX | Eloxx Pharmaceuticals | $54.28M |
| INKT | MiNK Therapeutics | $53.73M |
| PLRX | Pliant Therapeutics | $53.18M |
| EUDA | EUDA Health Holdings | $52.99M |
| XLO | Xilio Therapeutics | $52.84M |
| HRTX | Heron Therapeutics | $52.72M |
| POCI | Precision Optics Corporation Inc. Common stock | $51.12M |
| IBIO | iBio | $49.43M |
| MYO | Myomo | $49.11M |
| HYPD | Hyperion DeFi | $48.95M |
| ZSTK | ZeroStack | $48.62M |
| KLRS | Kalaris Therapeutics | $48.32M |
| ANVS | Annovis Bio | $48.23M |
| LONA | LeonaBio | $46.54M |
| IMA | ImageneBio | $46.54M |
| ATNM | Actinium Pharmaceuticals Inc. (Delaware) | $46.53M |
| MREO | Mereo BioPharma Group | $46.23M |
| TIL | Instil Bio | $46.12M |
| ELTX | Elicio Therapeutics | $45.51M |
| SRTS | Sensus Healthcare | $45.44M |
| INMB | INmune Bio Inc. Common stock | $44.89M |
| SNWV | SANUWAVE Health | $44.30M |
| CCEL | Cryo-Cell International | $42.01M |
| ATHE | Alterity Therapeutics | $41.25M |
| GRCE | Grace Therapeutics | $40.81M |
| HBIO | Harvard Bioscience | $40.51M |
| ODYS | Odysight.ai | $39.72M |
| EXOZ | eXoZymes | $38.43M |
| TVGN | Tevogen | $38.42M |
| CVRX | CVRx | $37.57M |
| SCYX | SCYNEXIS | $37.51M |
| VERU | Veru | $37.34M |
| PTHS | Pelthos Therapeutics | $36.96M |
| TELA | TELA Bio | $36.57M |
| NSRX | Nasus Pharma | $35.96M |
| GRDX | GridAI Technologies | $35.37M |
| EDSA | Edesa Biotech Inc. Common Shares | $34.71M |
| NNVC | NanoViricides | $33.95M |
| ALDX | Aldeyra Therapeutics | $33.80M |
| PRPO | Precipio | $32.40M |
| ACET | Adicet Bio | $32.01M |
| IXHL | Incannex Healthcare | $31.61M |
| QTI | QT Imaging Holdings | $31.32M |
| EYPT | EyePoint | $30.04M |
| ALGS | Aligos Therapeutics | $29.98M |
| AARD | Aardvark Therapeutics | $29.76M |
| PMN | ProMIS Neurosciences Inc. Common Shares (ON) | $29.68M |
| DRIO | DarioHealth | $29.40M |
| PIII | P3 Health Partners | $29.26M |
| RYOJ | rYojbaba Co. Ltd. Common Shares | $29.22M |
| NXTC | NextCure | $28.88M |
| RMTI | Rockwell Medical | $28.49M |
| RNAZ | TransCode Therapeutics | $27.60M |
| CPHI | China Pharma Holdings | $26.88M |
| BYSI | BeyondSpring | $26.47M |
| BCTX | BriaCell Therapeutics Corp. Common Shares | $26.45M |
| EVAX | Evaxion A/S American Depositary Share | $26.43M |
| NNOX | NANO-X IMAGING LTD | $25.99M |
| PLRZ | Polyrizon | $25.50M |
| SHPH | Shuttle Pharmaceuticals Holdings | $24.54M |
| CVM | Cel-Sci | $24.27M |
| CRVO | CervoMed | $24.19M |
| IMMP | Immutep | $22.56M |
| QNRX | Quoin Pharmaceuticals | $21.81M |
| ATOS | Atossa Therapeutics | $21.65M |
| AYTU | Aytu BioPharma | $20.98M |
| NSPR | InspireMD | $20.92M |
| TXMD | TherapeuticsMD | $20.83M |
| QNTM | Quantum Biopharma Ltd. Class B Subordinate Voting Shares | $19.59M |
| ACH | Accendra Health | $19.56M |
| PMI | Picard Medical | $19.53M |
| COCP | Cocrystal Pharma | $19.17M |
| AKTX | Akari Therapeutics plc ADS | $18.83M |
| KYNB | Kyntra Bio | $18.50M |
| MCRB | Seres Therapeutics | $17.60M |
| BOLT | Bolt Biotherapeutics | $17.04M |
| RADX | Radiopharm Theranostics | $16.96M |
| RVP | Retractable Technologies | $16.91M |
| LFWD | Lifeward | $16.86M |
| ARAY | Accuray Incorporated | $16.74M |
| NEUP | Neuphoria Therapeutics | $16.50M |
| MRKR | Marker Therapeutics | $16.34M |
| MODD | Modular Medical | $16.33M |
| AQB | AquaBounty Technologies | $15.82M |
| SCLX | Scilex Holding Company | $15.71M |
| PAVM | PAVmed | $15.59M |
| CCM | Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares) | $15.50M |
| DYAI | Dyadic International | $15.23M |
| CTXR | Citius Pharmaceuticals | $14.36M |
| CTSO | Cytosorbents | $14.31M |
| DARE | Dare Bioscience | $13.76M |
| NCEL | NewcelX | $13.73M |
| BNGO | Bionano Genomics | $13.54M |
| PLSM | Pulsenmore | $13.39M |
| BCDA | BioCardia | $13.03M |
| SINT | SiNtx Technologies | $12.85M |
| PBM | Psyence Biomedical Ltd. Common Shares | $12.62M |
| IRIX | IRIDEX | $12.50M |
| BIVI | BioVie | $12.20M |
| LPCN | Lipocine | $11.87M |
| CLRB | Cellectar Biosciences | $11.39M |
| ASBP | Aspire-Lakewood Holdings | $11.38M |
| PASG | Passage Bio | $11.10M |
| INTS | Intensity Therapeutics Inc. Common stock | $11.10M |
| LSTA | Lisata Therapeutics | $11.02M |
| GTBP | GT Biopharma | $10.96M |
| TVRD | Tvardi Therapeutics | $10.58M |
| PHIO | Phio Pharmaceuticals | $9.99M |
| BLRX | BioLineRx | $9.91M |
| LTRN | Lantern Pharma | $9.87M |
| RGNT | Regentis Biomaterials | $9.62M |
| CLGN | CollPlant Biotechnologies | $9.36M |
| PTN | Palatin Technologies | $8.90M |
| INM | InMed Pharmaceuticals Inc. Common Shares | $8.79M |
| AEMD | Aethlon Medical | $8.73M |
| MBRX | Moleculin Biotech | $8.29M |
| BMRA | Biomerica | $7.91M |
| SNGX | Soligenix | $7.75M |
| UPC | Universe Pharmaceuticals | $7.49M |
| VTGN | Vistagen Therapeutics | $7.47M |
| MEDS | DataMeds AI | $7.42M |
| LEXX | Lexaria Bioscience | $7.35M |
| CNSP | CNS Pharmaceuticals | $7.30M |
| NDRA | ENDRA Life Sciences | $7.12M |
| XTLB | XTL Biopharmaceuticals | $6.83M |
| XCUR | Exicure | $6.61M |
| ENVB | Enveric Biosciences | $6.40M |
| AIM | AIM ImmunoTech | $6.16M |
| APRE | Aprea Therapeutics Inc. Common stock | $6.10M |
| SNES | SenesTech | $5.86M |
| ACON | Aclarion | $5.62M |
| LGVN | Longeveron | $5.32M |
| PCSA | Processa Pharmaceuticals | $5.29M |
| SNOA | Sonoma Pharmaceuticals | $5.27M |
| PULM | Pulmatrix | $5.11M |
| EVGN | Evogene | $5.09M |
| TRIB | Trinity Biotech | $5.09M |
| CANF | Can-Fite Biopharma Ltd American Depositary Shares each representing two (2) | $4.92M |
| XBIO | Xenetic Biosciences | $4.80M |
| NVNO | enVVeno Medical | $4.68M |
| NCNA | NuCana plc American Depositary Share | $4.35M |
| YCBD | cbdMD | $4.29M |
| VVOS | Vivos Therapeutics | $3.82M |
| ADVB | Advanced Biomed | $3.80M |
| BIAF | bioAffinity Technologies | $3.73M |
| XAIR | Beyond Air | $3.73M |
| QCLS | Q/C Technologies | $3.56M |
| AMIX | Autonomix Medical | $3.55M |
| CVKD | Cadrenal Therapeutics | $3.51M |
| RDHL | Redhill Biopharma | $3.45M |
| ADXN | Addex Therapeutics | $3.28M |
| CODX | Co-Diagnostics | $3.24M |
| ERNA | Ernexa Therapeutics | $3.22M |
| KALA | KALA BIO | $3.20M |
| MBIO | Mustang Bio | $3.03M |
| ENLV | Enlivex | $2.73M |
| DCOY | Decoy Therapeutics | $2.55M |
| CRIS | Curis | $2.46M |
| APVO | Aptevo Therapeutics | $2.43M |
| SXTC | China SXT Pharmaceuticals | $2.23M |
| PRFX | PRF Technologies | $2.22M |
| WORX | SCWorx | $2.22M |
| PPBT | Purple Biotech | $1.90M |
| GNPX | Genprex | $1.84M |
| OGEN | Oragenics | $1.69M |
| GOVX | GeoVax Labs | $1.53M |
| MTNB | Matinas Biopharma Holdings | $1.48M |
| SPRC | SciSparc | $1.39M |
| VJET | Flyte Aviation | $1.23M |
| ARTL | Artelo Biosciences | $1.22M |
| AKAN | Akanda Corp. Common Shares | $562,640 |
| INO | Inovio Pharmaceuticals | |
| JAGX | Jaguar Health | |
| KPTI | Karyopharm Therapeutics |
The two-week call for each stock is on its stock page.
Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 2, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.